Lab
Shore Health System, INC.
Shore Health System, INC. was paid $1.17M by Medicaid between Nov 2021 and Dec 2024, across 90 billing codes. Its largest line is 87636, Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B — 14% of everything it billed.
33Billing provider infoSHORE HEALTH SYSTEM, INC.
EASTON, MD 21601
EASTON, MD 21601
33aNPI1558963280assigned 11/09/2020
33bProvider typeClinical Medical Laboratory
28Total paid$1.17M
24GClaims116,633
24DCodes billed90
24AFirst – last monthNov 2021 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Maryland
Rank by total paid#36 of 93
Median peer was paid$430K
This provider vs. median2.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KOZEL, KENNETH controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 92 | $195.82 | |
| 2022 | 28,686 | $256K | |
| 2023 | 48,077 | $502K | |
| 2024incomplete | 39,778 | $413K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 14% | 1,758 | 970 | $159K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 12% | 1,287 | 990 | $144K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 10% | 1,581 | 1,172 | $120K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 6.0% | 941 | 809 | $70K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 5.7% | 481 | 443 | $66K |
| 36415 | Collection of venous blood by venipuncture | 5.0% | 14,564 | 10,857 | $59K |
| 80053 | Comprehensive metabolic panel | 3.4% | 7,608 | 5,444 | $40K |
| 80061 | Lipid panel | 2.8% | 4,558 | 3,550 | $33K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.7% | 8,352 | 5,799 | $32K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.7% | 1,816 | 1,320 | $32K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.7% | 1,815 | 1,319 | $31K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.5% | 2,850 | 2,155 | $30K |
78 more codes
| 88342 | 2.5% | 587 | $29K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.0% | 3,063 | $23K |
| 88142 | 1.5% | 2,197 | $18K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.5% | 3,644 | $18K |
| 86780 | 1.4% | 2,625 | $16K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.3% | 934 | $16K |
| 82728 | 1.2% | 2,347 | $14K | |
| 86703 | 1.2% | 2,112 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.0% | 2,896 | $12K |
| 86803 | <1% | 1,711 | $11K | |
| 84439 | <1% | 2,045 | $10K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 208 | $8K |
| 85027 | <1% | 2,351 | $8K | |
| 82607 | <1% | 1,382 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,691 | $7K |
| 87081 | <1% | 1,912 | $7K | |
| 83550 | <1% | 1,748 | $7K | |
| 86762 | <1% | 1,091 | $7K | |
| 86850 | <1% | 1,577 | $7K | |
| 87340 | <1% | 1,448 | $7K | |
| 87077 | <1% | 1,879 | $7K | |
| 84702 | <1% | 819 | $6K | |
| 86787 | <1% | 1,073 | $6K | |
| 83540 | <1% | 2,071 | $6K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,713 | $6K |
| 83970 | <1% | 302 | $5K | |
| 80074 | <1% | 196 | $5K | |
| 82105 | <1% | 653 | $5K | |
| 83655 | <1% | 648 | $4K | |
| 82570 | <1% | 1,524 | $4K | |
| 82746 | <1% | 1,100 | $3K | |
| 86140 | <1% | 1,060 | $3K | |
| 88141 | <1% | 155 | $3K | |
| 87186 | <1% | 742 | $3K | |
| 84480 | <1% | 519 | $3K | |
| 84146 | <1% | 261 | $3K | |
| 83735 | <1% | 1,093 | $3K | |
| 81001 | <1% | 1,531 | $3K | |
| 82043 | <1% | 776 | $2K | |
| 82950 | <1% | 963 | $2K | |
| 86900 | <1% | 1,583 | $2K | |
| 86901 | <1% | 1,581 | $2K | |
| 85610 | <1% | 963 | $2K | |
| 84403 | <1% | 345 | $2K | |
| 86038 | <1% | 357 | $2K | |
| 84156 | <1% | 785 | $1K | |
| 83001 | <1% | 145 | $1K | |
| 84466 | <1% | 170 | $1K | |
| 84550 | <1% | 495 | $1K | |
| 85652 | <1% | 1,225 | $1K | |
| 84153 | <1% | 112 | $1K | |
| 86003 | <1% | 121 | $868.41 | |
| 87088 | <1% | 185 | $789.22 | |
| 85730 | <1% | 249 | $696.30 | |
| 82670 | <1% | 44 | $617.44 | |
| 86480 | <1% | 15 | $604.35 | |
| 85018 | <1% | 518 | $587.07 | |
| 85014 | <1% | 499 | $561.96 | |
| 87070 | <1% | 166 | $553.31 | |
| 83615 | <1% | 218 | $547.78 | |
| 82784 | <1% | 241 | $513.29 | |
| 83002 | <1% | 49 | $468.63 | |
| 86618 | <1% | 15 | $310.17 | |
| 82785 | <1% | 67 | $272.95 | |
| 83516 | <1% | 77 | $243.55 | |
| 84100 | <1% | 107 | $209.02 | |
| 83690 | <1% | 52 | $201.70 | |
| 86364 | <1% | 30 | $166.48 | |
| 83021 | <1% | 15 | $149.01 | |
| 86431 | <1% | 84 | $134.72 | |
| 80076 | <1% | 28 | $132.86 | |
| 86376 | <1% | 28 | $132.44 | |
| 86039 | <1% | 34 | $116.00 | |
| 87205 | <1% | 63 | $90.02 | |
| 81003 | <1% | 64 | $78.12 | |
| 82248 | <1% | 15 | $47.96 | |
| 84402 | <1% | 60 | $3.53 | |
| 80050 | General health panel | 0% | 1,570 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKOZEL, KENNETH (PRESIDENT/CEO)
Parent organizationSHORE HEALTH SYSTEM, INC
| Provider | Location | Paid |
|---|---|---|
| Shore Health System, INC | Easton, MD | $5.28M |
| Shore Health System INC | Easton, MD | $1.07M |
| Chester River Hospital Center | Chestertown, MD | $627K |
| Shore Health System, INC | Easton, MD | $392K |
| Shore Health System, INC | Cambridge, MD | $349K |
| Chester River Hospital Center | Chestertown, MD | $137K |
| Shore Health System, INC | Cambridge, MD | $115K |
| Shore Health System, INC | Easton, MD | $57K |
| Shore Health System INC | Denton, MD | $40K |
| Um Shore Regional Health, INC | Chestertown, MD | $21K |
| Shore Health System, INC. | Easton, MD | $7K |
| Shore Health System, INC | Easton, MD | $3K |
| Shore Health System, INC | Queenstown, MD | $715.74 |
| Shore Health System, INC. | Easton, MD | $-0.04 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.